Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Olfactory alterations in patients with multiple sclerosis.
Olfactory dysfunction as a marker of multiple sclerosis progression.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.
Use of natalizumab in multiple sclerosis: current perspectives.
Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.
Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
[Diagnostics and treatment of trigeminal neuralgia].
MtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
[Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele].
Optic neuropathy associated with systemic sarcoidosis.
Gut microflora and multiple sclerosis.
Ultrastructural pathology of human peritumoural oedematous cerebellar cortex.
Probiotics Lactobacillus plantarum and bifidobacterium B94: cognitive function in demyelinated model.
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.
g-Ratio weighted imaging of the human spinal cord in vivo.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Pages
« first
‹ previous
…
820
821
822
823
824
825
826
827
828
…
next ›
last »